# GPT-5-mini Review

**Role:** External referee review
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T22:46:45.824820
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 15113 in / 5739 out
**Response SHA256:** 25fe0ff2b8156ce9

---

Thank you for the opportunity to review this well-motivated and policy-relevant manuscript. The topic—what happens to financing of childbirth when young adults age out of parental dependent coverage at 26—is important, and the paper exploits a plausible institutional margin and a very large administrative dataset. The paper has promise. However, several serious methodological and presentation issues must be addressed before this could be considered for a top general-interest journal. Below I give a comprehensive review organized according to your requested rubric: format, statistical methodology (critical), identification, literature, writing quality, constructive suggestions, overall assessment, and a recommendation.

SUMMARY ASSESSMENT (brief)
- Core finding: at the age-26 cutoff, Medicaid-financed births increase by about 2.7 percentage points and private-insurance-financed births fall by about 3.1 percentage points (Sections 7–9).
- Strengths: policy relevance, very large administrative sample (CDC natality), clear focal outcome (payment at delivery), complementary estimation approaches (rdrobust local polynomial, local randomization / permutation), heterogeneity (marital status, education).
- Main concerns (must be resolved): discrete running variable and measurement of the cutoff (age measured in integer years; plan termination timing varies), placebo discontinuities at other ages (Section “Validity Tests”), lack of formal McCrary/manipulation diagnostics appropriate for discrete data, and lack of explicit fuzzy-RD treatment for the documented variation in timing of coverage termination. These problems raise serious threats to identification and the causal interpretation of point estimates.

1. FORMAT CHECK
- Length: The LaTeX source contains a full paper with abstract, introduction, conceptual sections, institutional background, data, empirical strategy, results, validity tests, heterogeneity, discussion, and an appendix. Based on the sections and content provided, I estimate the manuscript to be roughly 25–35 pages excluding references/appendix. If the compiled PDF is under 25 pages (excluding refs/appendix), the paper would fail your length criterion for top general-interest journals. Please confirm and, if needed, expand exposition in methods, robustness, and appendix tables/figures.
- References: The bibliography is substantial and cites many relevant empirical and RD-methodology papers (Calonico et al. 2014; Cattaneo et al. 2015/2019; Kolesár & Rothe 2018; Card et al.; Sommers et al.). However, some canonical RD/methodology and DiD methodological references are missing (see Section 4 below for exact missing citations and BibTeX).
- Prose: Major sections (Introduction, Conceptual Framework, Institutional Background, Data, Empirical Strategy, Results, Validity Tests, Heterogeneity, Discussion) are written in paragraph form, not bullets. Good.
- Section depth: Most major sections contain multiple substantive paragraphs. However, some subsections (e.g., “Data Appendix,” parts of the Institutional Background) could be expanded with more explicit discussion of measurement issues. Each major section generally has 3+ substantive paragraphs—acceptable.
- Figures: Figures appear to show the data and are described (e.g., Figure 1 and the density histogram). However, the LaTeX includes external figure files (figures/figure1_rdd_main.pdf, density_test.pdf, etc.). In revision please ensure all figures have legible axes, unit labels, and sample counts on axes. The manuscript currently gives good captions but the uploaded LaTeX source does not allow me to inspect axis labels/font sizes—verify in the compiled PDF.
- Tables: The paper references several tables (Table 1 summary, Table 2 main results, etc.) and inputs external table files. Ensure all tables in the submitted PDF contain real numeric estimates, standard errors, confidence intervals, and N (they appear to do so in-text, but confirm in final PDF).

2. STATISTICAL METHODOLOGY (CRITICAL)
I treat methodology as decisive. A paper CANNOT pass review without rigorous statistical inference and a credible identification strategy.

a) Standard Errors
- The manuscript reports standard errors and robust bias-corrected confidence intervals from rdrobust (Section 6 and Table 2). The main coefficients include SEs (e.g., Medicaid effect 0.027, SE = 0.005) and 95% CIs are reported in places. N is reported (1,644,832 births). This satisfies the baseline requirement that coefficients have SEs/CIs.

b) Significance Testing
- Yes: hypothesis tests and permutation p-values are reported (local randomization permutation p-value < 0.001 in Appendix).

c) Confidence Intervals
- 95% CIs are reported for main estimates (e.g., [0.018, 0.036]). Good.

d) Sample Sizes
- The manuscript reports sample sizes (Section 5: final sample 1,644,832 births). For regressions the rdrobust bandwidth-specific sample sizes should also be reported in tables/notes—please add N used in each RD estimate (rdrobust reports local sample sizes).

e) DiD with Staggered Adoption
- Not applicable (paper uses RD).

f) RDD: Bandwidth sensitivity and McCrary
- Bandwidth sensitivity: The paper reports a bandwidth sensitivity figure (Figure 7) and states estimates stable across bandwidths 2–5 years. Good.
- McCrary / density / manipulation test: The manuscript presents a histogram (Figure “density_test.pdf”) and states “no visible bunching” (Section “Validity Tests”), but it does not present a formal McCrary (2008) density test / p-value or a version suitable for discrete running variables. Given the running variable is integer age—thus discrete and with mass points—the standard McCrary test is not directly appropriate without adjustments. Kolesár & Rothe (2018) discuss inference with discrete running variables; the manuscript cites Kolesár & Rothe, but does not present formal discrete-density tests or supply p-values. This omission is important: absence of visible bunching in a histogram is weaker evidence than a formal test appropriate for discrete data. Please perform and report formal density tests appropriate for discrete age (or implement the permutation/randomization tests for the assignment mechanism in the small window), and report test statistics and p-values.

g) Additional critical methodological problems (summary)
- Discrete running variable in integer years: This is the paper’s central methodological challenge. Age is given as MAGER (single year of age). Comparing all 25-year-olds to all 26-year-olds is not the canonical continuous RD; it is a discontinuity across coarse age bins. The authors acknowledge this (Section 6), implement Kolesár & Rothe-aware variance estimators, local randomization comparing 25 vs 26, and difference-in-means as a baseline. Those are helpful; but they do not fully resolve two related issues:
  1) Policy timing fuzziness: the dependent coverage termination is implemented in practice at slightly different moments across plans (end of birthday month, end of plan year, exact birthday). Thus the policy cutoff in practice is fuzzy relative to observed integer age. This implies a fuzzy RD or measurement-error-in-cutoff approach is required; the paper treats D_i = 1[A_i >= 26] as a sharp treatment. The authors note the variability but do not implement a fuzzy RD that uses a first-stage (probability of losing parental coverage) or instrument for losing dependent coverage. Without this, the LATE interpretation is unclear and point estimates may be biased.
  2) Placebo discontinuities at other ages: Placebo tests (Table in “Validity Tests”) show statistically significant discontinuities at ages other than 26 (e.g., age 24 and 27). This suggests strong nonlinearity in the age→payment relationship and that local polynomial specification and bandwidth choices matter. The existence of multiple significant placebo “effects” undermines confidence that the age 26 jump is exclusively due to the dependent coverage provision. The authors argue that the sign at 26 is opposite to placebo signs and that local randomization comparing 25 vs 26 remains valid. That is not sufficient for a top-journal standard. The authors must show that the estimated effect at 26 is robust to the nonlinearity problem—e.g., by (i) obtaining exact-age (in days) data if possible; (ii) implementing an RD in age-in-months or days (restricted CDC or state data); (iii) using a fuzzy RD with an instrument/predicted discontinuity in parental coverage; or (iv) showing placebo discontinuities vanish when using the same narrow local randomization approach (e.g., randomization inference confined to a narrow window around 25–26 and showing other ages' local randomization tests produce null effects). At present this is the largest threat to identification.

Conclusion on methodology: The paper makes a serious effort to handle discrete running variable problems, uses recommended RD tools (rdrobust, local randomization), and reports SEs/CIs and bandwidth sensitivity. Nevertheless, two critical methodological deficiencies remain: failure to implement a fuzzy RD or otherwise model the variation in plan termination timing; and insufficiently convincing treatment of placebo discontinuities and density/manipulation tests for discrete data. Because of these flaws, I cannot recommend acceptance in top journals until they are addressed. If the authors can secure restricted data with exact dates of mother’s birth and infant’s birth (allowing an RD at the true birthday) or otherwise implement convincing fuzzy-RD and discrete-density tests, the paper would become much stronger.

If the methodology cannot be fixed (e.g., the authors cannot obtain exact-date data or build a credible fuzzy RD), then the paper is not publishable in a top general-interest journal in its current form. It might be publishable in a field journal if the limits are made explicit and the claims restrained to descriptive evidence.

3. IDENTIFICATION STRATEGY
- Credibility: The institutional motivation is convincing: age-26 dependent coverage ends. The idea of an RD at age 26 is sensible.
- Key assumptions discussed: The author states the continuity assumption (Section 6) and provides several validity tests (density, covariate balance, placebo). They explicitly note threats: discrete age, plan variation in cutoff, nonlinearity of age trends.
- Placebo tests & robustness: Placebo tests show problematic discontinuities at other ages (Section “Validity Tests”), which critically weakens causal claims. The authors present bandwidth sensitivity and local randomization as robustness checks. But additional robustness is needed: (a) a formal fuzzy RD or first-stage estimate of parental-coverage loss at the cutoff; (b) RD using exact-age running variable (days/months) if possible; (c) covariate balance and manipulation tests in the same narrow window and their p-values; (d) demonstrate that placebo ages show null effects in the same local-randomization narrow-window framework.
- Do conclusions follow from evidence? Tentatively: the observed jump in Medicaid-financed births at the integer-age boundary is consistent with the proposed mechanism, and heterogeneity by marital status/education lends plausibility (Section 9). But because of the discrete measurement and placebo irregularities, the causal interpretation (policy-induced municipal shift) is not yet airtight. The fiscal back-of-envelope is useful but should be framed explicitly as conditional on the causal interpretation.
- Limitations discussed: The paper acknowledges several limitations (discrete age, measurement of payment only at delivery, lack of detectable health outcome effects). This is good; the authors should more strongly caveat causal claims given the methodological concerns above.

4. LITERATURE (missing / should add)
The literature review is generally strong, but for a paper centered on RD design and discrete running variables (and that positions itself as methodological as well as empirical), the following key references should be included and discussed. I provide short notes on relevance and BibTeX entries.

a) Imbens & Lemieux (2008) — foundational for RD methods, covariate balance discussion, and interpretation.
- Why relevant: Provides canonical RD framework and practice guidance; it is standard to cite when using RD.
BibTeX:
@article{ImbensLemieux2008,
  author = {Imbens, Guido and Lemieux, Thomas},
  title = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year = {2008},
  volume = {142},
  pages = {615--635}
}

b) Lee & Lemieux (2010) — authoritative RD survey; helpful for discussing identification, manipulation, and implementation.
BibTeX:
@article{LeeLemieux2010,
  author = {Lee, David S. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year = {2010},
  volume = {48},
  pages = {281--355}
}

c) McCrary (2008) — density test for RD; even if the standard test is not directly applicable to discrete age, the paper should discuss and cite McCrary and discrete adaptations.
BibTeX:
@article{McCrary2008,
  author = {McCrary, Justin},
  title = {Manipulation of the Running Variable in the Regression Discontinuity Design},
  journal = {Journal of Econometrics},
  year = {2008},
  volume = {142},
  pages = {698--714}
}

d) Goodman-Bacon (2021) and Callaway & Sant’Anna (2021) — even though not directly used (paper uses RD, not DiD), these are foundational for evaluating age-based policy evaluations and for positioning vis-à-vis DiD literature that the paper contrasts with.
- Good to cite when discussing DiD literature the paper replaces with RD.
BibTeX (Goodman-Bacon):
@article{GoodmanBacon2021,
  author = {Goodman-Bacon, Andrew},
  title = {Difference-in-Differences with Variation in Treatment Timing},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  pages = {254--277}
}
BibTeX (Callaway & Sant'Anna):
@article{CallawaySantAnna2021,
  author = {Callaway, Brantly and Sant'Anna, Pedro H. C.},
  title = {Difference-in-Differences with Multiple Time Periods},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  pages = {200--230}
}

e) Papers on fuzziness of "administrative cutoffs" and imperfect implementation / measurement error in cutoff (e.g., Lee & Lemieux discuss fuzzy RD briefly; also Cattaneo et al. 2019 book discusses practical issues). If the plan-level variation is large, cite literature on fuzzy RD and measurement error in running variable / cutoff (e.g., Staub & others). Specific references:
- For fuzzy RD:
@article{ImbensAngrist1994,
  author = {Imbens, Guido W. and Angrist, Joshua D.},
  title = {Identification and Estimation of Local Average Treatment Effects},
  journal = {Econometrica},
  year = {1994},
  volume = {62},
  pages = {467--475}
}
(Useful to motivate LATE interpretation and first-stage necessity.)

f) Kolesár & Rothe (2018) is cited already; be sure to expand discussion of their practical recommendations for discrete running variables and inference.

g) If space allows, cite recent specific studies looking at dependent coverage effects on births or maternal care (Daw & Sommers 2018 is cited; add any other recent papers focusing on maternal insurance churn e.g., studies on postpartum Medicaid churn, though those may be more specialized).

Explain why each is relevant: I have indicated this above; in the revision the authors should explicitly discuss how their RD approach complements / improves on prior DiD attempts and supply a clearly delineated methodological literature positioning (Imbens/Lee/Calonico/Cattaneo/Kolesár).

5. WRITING QUALITY (CRITICAL)
Overall the manuscript is well written and readable; it tells a clear story, motivates the question, and places it in context. Still, for top journals writing must be precise and candid about limitations.

a) Prose vs. Bullets: Satisfies the requirement—no major sections are in bullets. Good.

b) Narrative Flow: The paper has a sensible arc (motivation → context → methodology → results → heterogeneity → policy implications). The Introduction hooks the reader with vivid description of the seam and childbirth stakes. Good.

c) Sentence Quality: Generally crisp and active-voice. A few paragraphs (especially in Institutional Background) are long and could be tightened. Avoid rhetorical flourishes (“seams create suffering”) that may distract; keep a neutral academic tone in some passages.

d) Accessibility: The paper is largely accessible to an intelligent non-specialist. However, the econometric issues around discrete running variables, fuzziness of policy implementation, and placebo irregularities should be explained in plain language in the Methods and in the Introduction so non-experts appreciate why the identification is challenging and what was done to address it.

e) Figures/Tables: Captions are informative. In the final version make sure all figures are self-explanatory (axes labelled with percentages, sample counts, and clear legend for payment categories). For tables, put sample sizes and bandwidths in the notes.

6. CONSTRUCTIVE SUGGESTIONS (technical and substantive)
If the paper is to meet top-journal standards, the authors should address the following (in roughly this order of priority):

A. Obtain exact-age running variable (date of mother’s birth and infant birth) if at all possible
- The single most important improvement would be to use exact age in days (or months). That would allow an RD centered at the true birthday, avoid the coarse-age problem, permit a canonical continuous RD, and enable a formal McCrary test and other continuous-RD diagnostics. Many researchers obtain restricted CDC natality data or state-level vital-statistics access for such purposes. If feasible, request restricted access and rerun the RD. This would likely resolve most identification concerns.

B. If exact dates are not obtainable, implement a rigorous fuzzy RD or an instrumental-variables approach
- Because plan termination timing varies (end of birthday month, end of month, end of plan year), D_i = 1[A_i >= 26] is not a sharp indicator of losing parental coverage. Construct a first-stage: estimate probability of parental-coverage loss at age 26 using survey data (e.g., MEPS or NHIS) or administrative plan-level rules if available; use this as the instrument (fuzzy RD) to recover a LATE. Alternatively, frame the analysis as intent-to-treat (ITT) but be explicit: current estimates are ITT; if so, present first-stage estimates (what fraction of women actually lose parental coverage at the cutoff). Without a first-stage, magnitudes are hard to interpret.

C. Address the placebo discontinuities and age nonlinearity more convincingly
- Perform local-randomization permutation tests at many ages in the same narrow-window manner you use for 25 vs 26; show that placebo ages are null under this framework. Show that the age 26 effect is unique when using very narrow windows around the cutoff (e.g., comparing ages 25.5–26.5 if months available, or using alternative groupings).
- Alternatively, estimate flexible polynomial or spline-based age trends that allow arbitrary nonlinear age relationships and show that the discontinuity at 26 persists when conditioning on such flexible trends and small bandwidths.

D. Report formal discrete-density tests / manipulation checks
- Implement discrete-variable density tests (see Kolesár & Rothe, or recent discrete density test literature). Report test statistics and p-values. If the density is smooth, state that formally.

E. Provide the precise RD estimators’ local sample sizes and first-stage (if fuzzy)
- For each rdrobust estimate, report the bandwidth, local N (observations below and above within the bandwidth), and effective sample size. If you implement fuzzy RD, report first-stage strength (F-statistic).

F. Tighten treatment of heterogeneity and mechanisms
- The marital-status heterogeneity is persuasive and aligns with the mechanism. Strengthen this by showing pre-birth insurance coverage (if possible) or linking to external data (e.g., survey estimates of parental coverage by age/marital status) to show pre-cutoff parental coverage rates decline at 26 for unmarried women. If possible, use state-level or plan-level variables to show that the changes are larger where parental plans are more prevalent.

G. Health outcomes and power
- The null effects on prenatal care, preterm birth, and low birth weight are plausible. However, present power calculations or minimal detectable effects to show whether the study could detect plausible health impacts. If you can link to claims/insurance data for prenatal-care timing, do so.

H. Policy friction: variation in plan termination rules
- The paper notes that plan rules vary; consider exploiting this variation if data are available (e.g., if some states/plans terminate at end-of-month and others at birthday). That variation could serve as a source of plausibly exogenous variation in effective cutoff timing, enabling a stronger RD/fuzzy-RD or difference-in-discontinuities design.

I. Clarify and limit causal claims if issues remain
- If after exhaustive effort the authors cannot fully remove doubts about the discrete-running-variable identification, they should recast claims more modestly (descriptive evidence of a sharp change across integer age, strongly suggestive of policy effect) and explicitly state caveats.

J. Presentation and reproducibility
- Provide rdrobust options used (bandwidth selector, polynomial order, kernel), and provide code in a public repository. The abstract references a GitHub for an original version—update with code and figures so reviewers can reproduce the results.

7. OVERALL ASSESSMENT
- Key strengths:
  - Large, near-universal administrative dataset (CDC natality).
  - Clear, policy-relevant question with immediate fiscal and human implications.
  - Reasonable econometric toolkit used (rdrobust, local randomization).
  - Heterogeneity analysis (marital status, education) helps support the mechanism.

- Critical weaknesses:
  - Running variable measured in integer years (MAGER) creates a coarse/discrete RD; the cutoff is implemented with plan-specific timing variation, implying the practical RD is fuzzy.
  - Placebo discontinuities at other ages undermine confidence that the 26 jump is policy-driven rather than functional-form/artifact of age nonlinearity.
  - No formal discrete-density (McCrary-style) test results or p-values for manipulation; visual histogram is insufficient.
  - No first-stage estimate or fuzzy-RD implementation to account for imperfect compliance with the cutoff.
  - Health-outcome null results are presented without power calculations; this undercuts claims about no health effects.

- Specific suggestions for improvement:
  1) Obtain exact birthdate data and rerun RD at the true birthday if feasible.
  2) Implement a fuzzy RD (or instrument) to account for plan-variation in the effective cutoff; present first-stage and LATE.
  3) Run and report discrete-density / formal manipulation tests with p-values.
  4) Address placebo discontinuities by restricted-window local randomization or by flexible spline trends, and demonstrate uniqueness of the 26 effect.
  5) Report local sample sizes, bandwidths, p-values, and power bounds for health outcomes.
  6) Add the missing canonical methodological citations (Imbens & Lemieux 2008; Lee & Lemieux 2010; McCrary 2008; Imbens & Angrist 1994; Goodman-Bacon; Callaway & Sant’Anna).

DECISION
Given the importance of the question but the current methodological concerns (discrete running variable, fuzzy implementation of the cutoff, and placebo discontinuities), I recommend major revision. The paper is potentially publishable in a top journal if the authors can convincingly address the discrete-running-variable/fuzziness issues (preferably by obtaining exact-age data or by implementing a credible fuzzy RD and stronger placebo/density tests) and temper or clarify causal claims pending those fixes.

DECISION: MAJOR REVISION